Anzeige
Mehr »
Login
Mittwoch, 19.02.2020 Börsentäglich über 12.000 News von 619 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 872983 ISIN: US4529071080 Ticker-Symbol: IM3 
Frankfurt
19.02.20
08:04 Uhr
17,030 Euro
+0,234
+1,39 %
1-Jahres-Chart
IMMUNOMEDICS INC Chart 1 Jahr
5-Tage-Chart
IMMUNOMEDICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
17,006
17,162
11:37
16,998
17,154
11:37

Aktuelle News zur IMMUNOMEDICS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrImmunomedics nabs J&J veteran for CMO as it presses on with ADC redo8
FrImmunomedics, Inc.: Immunomedics Appoints Dr. Loretta Itri Chief Medical Officer2
IMMUNOMEDICS Aktie jetzt für 4€ handeln
FrIMMUNOMEDICS INC - 8-K, Current Report1
23.01.Immunomedics Competitor Threatens To Leapfrog Approval With Breakthrough Therapy Designation11
22.01.Immunomedics: A Promising Cancer Player For 202010
27.12.19FDA Accepts Immunomedics' BLA Refiling for Breast Cancer Drug15
26.12.19FDA accepts Immunomedics' refiled sacituzumab govitecan application11
26.12.19Immunomedics, Inc.: Immunomedics Announces FDA Acceptance for Filing of Biologics License Application Resubmission for Sacituzumab Govitecan to Treat ...8
26.12.19IMMUNOMEDICS INC - 8-K, Current Report1
09.12.19IMMUNOMEDICS INC - 8-K, Current Report4
09.12.19Immunomedics, Inc.: Immunomedics Announces Closing of Public Offering of Common Stock4
07.12.19Immunomedics: Updates To Thesis, Buy The Secondary13
07.12.19Why Immunomedics Shares Surged 11.3% Today14
05.12.19Immunomedics Resubmits Application for Breast Cancer Drug12
05.12.19Troubled Immunomedics tries again at FDA after rejection7
05.12.19Immunomedics prices $250M equity offering12
05.12.19Immunomedics, Inc.: Immunomedics Announces Pricing of Public Offering of Common Stock2
04.12.19Why Dynatrace, Revance Therapeutics, and Immunomedics Slumped Today9
04.12.19Nearly a year after surprise rejection, Immunomedics returns to FDA7
03.12.19Immunomedics, Inc.: Immunomedics Announces Proposed Public Offering of Common Stock9
Seite:  Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1